Reassessing physician interactions with pharmaceutical companies: A response to Murayama et al. and analysis of survey discrepancies

Int J Health Plann Manage

Ozaki A, Saito H, Endo M, Takebayashi Y, Murakami M

2024/9/1

https://pubmed.ncbi.nlm.nih.gov/39217622/